UCP2 and colonic neoplasm: Similarly, overexpression of UCP2 in a human colon cancer cell line has been shown to blunt topoisomerase I inhibitor CPT-11-induced accumulation of reactive oxygen species and apoptosis in vitro and to confer CPT-11 resistance of tumor xenografts (Derdak et al., 2008).